Swetha Makkapati

Swetha Makkapati practices at Winchester Dialysis in Winchester, Virginia.

Swetha Makkapati's NPI, 1629335880, was assigned on April 12, 2012. Swetha Makkapati holds Arkansas license E-10602.

Swetha Makkapati's primary practice is Winchester Dialysis, at 812 Amherst St, Winchester, VA 22601 in Winchester City. The practice phone is (540) 667-0227.

Swetha Makkapati's primary practice is Winchester Dialysis in Winchester, Virginia. Swetha Makkapati is also affiliated with Winchester Medical Center. The medical group on file is Renal Physician Associates. Dmand AI also links Swetha Makkapati to 5 more hospitals, 3 dialysis centers and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Swetha Makkapati practices, 10 sites in all. Vendor and product names are available with a free account.

Nephrology is Swetha Makkapati's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Swetha Makkapati is licensed in Arkansas.

CMS data shows 2,929 Medicare services from Swetha Makkapati across 16 procedure codes in 2024, for 898 Medicare patients. Medicare paid $236,639 for them.

CMS counts 898 Medicare patients who saw Swetha Makkapati in 2024. The largest group is 75 to 84, with 399 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 11% are also on Medicaid. Their average risk score is 3.23, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Swetha Makkapati's median patient age at 74, with 51% women.

In 2024, Swetha Makkapati wrote 1,242 Medicare Part D claims for 338 patients. 93% of them were for generic drugs. CMS names the drug for 1,031 of them, across 24 drugs with 11 or more claims each, at $94,023 in total drug cost. In 2023, CMS named 1,180 claims across 24 drugs.

Swetha Makkapati accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Swetha Makkapati as offering telehealth.

CMS Open Payments shows 114 general payments to Swetha Makkapati from 27 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 90% of the total. Relypsa, Inc. paid the most, $329.